2,495
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

A ferroptosis-related gene signature for graft loss prediction following renal allograft

, , , &
Pages 4217-4232 | Received 07 May 2021, Accepted 01 Jul 2021, Published online: 01 Aug 2021

References

  • Loupy A, Lefaucheur C, Ingelfinger JR. Antibody-Mediated Rejection Of Solid-Organ Allografts. N Engl J Med. 2018;379:1150–1160.
  • Global Observatory on donation and transplantation home page. http://www.transplant-observatory.org/
  • Wekerle T, Segev D, Lechler R, et al. Strategies for long-term preservation of kidney graft function. Lancet. 2017;389:2152–2162.
  • Sellarés J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplanat. 2012;12:388–399.
  • Halloran PF, Ks F, Reeve J. Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol. 2016;12:534–548.
  • Lovisa S, LeBleu VS, Tampe B, et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998–1009.
  • Venner JM, Famulski KS, Reeve J, et al. Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight. 2016;1:e85323.
  • Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–1072.
  • Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273–285.
  • Lachaier E, Louandre C, Godin C, et al. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res. 2014;34:6417–6422.
  • Dzikiewicz-Krawczyk A, Kok K, Slezak-Prochazka I, et al. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma. Leukemia. 2017;31:1470–1473.
  • Masaldan S, Bush AI, Devos D, et al. Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration. Free Radic Biol Med. 2018;133:221–233.
  • Tuo QZ, Lei P, Jackman KA, et al. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke. Mol Psychiatry. 2017;22:1520–1530.
  • Sheng X, Shan C, Liu J, et al. Theoretical insights into the mechanism of ferroptosis suppression via inactivation of a lipid peroxide radical by liproxstatin-1. Phys Chem Chem Phys. 2017;19:13153–13159.
  • Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317–331.
  • Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62.
  • Guerrero-Hue M, García-Caballero C, Palomino-Antolín A, et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 2019;33:8961–8975.
  • Ma D, Li C, Jiang P, et al. Inhibition of ferroptosis attenuates acute kidney injury in rats with severe acute pancreatitis. Dig Diseases Sci. 2021;66:483–492.
  • Skouta R, Dixon SJ, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Soc. 2014;136:4551–4556.
  • Ding C, Ding X, Zheng J. miR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injury. Cell Death Discov. 2020;11:929.
  • Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res. 2007;35:D760–765.
  • Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl Acids Res. 2015;43:e47.
  • Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag. 2016.
  • Chen H, Boutros PC, Loupy A. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics. 2011;12:35.
  • Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287.
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
  • Therneau TM, Lumley T. Package ‘survival’. Survival analysis Published on CRAN. (2014) 2:3.
  • Gregg ME, Datta S, Lorenz D. A log rank test for clustered data with informative within-cluster group size. Stat Med. 2018;37:4071–4082.
  • Therneau TM, Package LT ‘survival’. Survival analysis Published on CRAN. (2014) 2: 3.
  • Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc B. 1996;58:267–288.
  • Friedman J, Hastie T, Tibshirani R. glmnet: lasso and elastic-net regularized generalized linear models. R package version. (2009) 1
  • Songyang Y, Zhu W, Liu C, et al. Large-scale gene expression analysis reveals robust gene signatures for prognosis prediction in lung adenocarcinoma. PeerJ. 2019;7:e6980.
  • Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92–105.
  • Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364–1370.
  • Petra H, Eva H, Irena B, et al. Molecular profiling of acute and chronic rejections of renal allografts. Clin Dev Immunol. 2013;(2013):509259.
  • Dennis MJ, Foster MC, Ryan JJ, et al. The increasing importance of chronic rejection as a cause of renal allograft failure. Transpl Int. 1989;2:214–217.
  • Furness PN, Taub N. Convergence of European Renal Transplant Pathology Assessment Procedures (CERTPAP) Project. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP project. Kidney Int. 2001;60:1998–2012.
  • Reeve J, Sellarés J, Mengel M, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplanat. 2013;13:645–655.
  • Qi W, Li Z, Xia L, et al. LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells. Sci Rep. 2019;9:16185.
  • Guo Y, Yuan X, Li K, et al. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer. Cell Death Differ. 2020;27:1862–1877.
  • Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancers. 2009;9:400–414.
  • Tarangelo A, Magtanong L, Bieging-Rolett KT, et al. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells. Cell Rep. 2018;22:569–575.
  • Al-Douahji M, Brugarolas J, Brown PA, et al. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int. 1999;56:1691–1699.
  • Yang J, Shen Y, Yang X, et al. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Am J Physiol Renal Physiol. 2019;317:F1350–F1358.
  • Megyesi J, Tarcsafalvi A, Li S, et al. Increased expression of p21WAF1/CIP1 in kidney proximal tubules mediates fibrosis. Am J Physiol Renal Physiol. 2015;308:F122–F130.
  • Megyesi J, Andrade L, Vieira JMJ, et al. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int. 2001;60:2164–2172.
  • Campbell M, Hile KL, Zhang H, et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res. 2011;168:e61–9.
  • Wang Y, Wang D. Z J. miR27a suppresses TLR4induced renal ischemiareperfusion injury. Mol Med Rep. 2019;20:967–976.
  • Anders HJ, Banas B, Schlöndorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15:854–867.
  • Ye Y, Zhang Y, Wang B, et al. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy. Biomed Pharmacother. 2018;107:1142–1150.
  • McRae JL, Vikstrom IB, Bongoni AK, et al. Blockade of the G-CSF Receptor Is Protective in a Mouse Model of Renal Ischemia-Reperfusion Injury. J Immunol. 2020;205:1433–1440.
  • Luo CJ, Luo F, Zhang L, et al. Knockout of interleukin-17A protects against sepsis-associated acute kidney injury. Ann Intensive Care. 2016;6:56.
  • Cohen AW, Hnasko R, Schubert W, et al. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84:1341–1379.
  • Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Biol. 2007;8:154–194.
  • Van Der Hauwaert C, Savary G, Pinçon C, et al. Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation. Fibrogenesis Tissue Repair. 2015;8:8.
  • Matsunami M, Rosales IA, Adam BA, et al. Long-term Kinetics of Intragraft Gene Signatures in Renal Allograft Tolerance Induced by Transient Mixed Chimerism. Transplantation. 2019;103:e334.
  • Luo Y, Shen D, Chen L, et al. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Aging (Albany NY). 2019;11:6029–6052.
  • Osako Y, Yoshino H, Sakaguchi T, et al. Potential tumorsuppressive role of microRNA99a3p in sunitinibresistant renal cell carcinoma cells through the regulation of RRM2. Int J Oncol. 2019;54:1759–1770.